| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 13.31M | 10.92M | 12.31M | 8.70M | 6.55M | 7.82M |
| Gross Profit | 10.45M | 9.31M | 10.57M | 7.35M | 5.86M | 6.29M |
| EBITDA | 871.00K | 183.00K | 643.00K | -38.00K | -305.00K | 69.00K |
| Net Income | 414.00K | -158.00K | 309.00K | -338.00K | -642.00K | -322.00K |
Balance Sheet | ||||||
| Total Assets | 4.82M | 4.43M | 5.21M | 4.13M | 4.26M | 3.82M |
| Cash, Cash Equivalents and Short-Term Investments | 174.00K | 236.00K | 765.00K | 50.00K | 459.00K | 367.00K |
| Total Debt | 309.00K | 619.00K | 439.00K | 1.46M | 1.70M | 1.07M |
| Total Liabilities | 2.98M | 3.15M | 3.83M | 3.46M | 3.43M | 2.72M |
| Stockholders Equity | 1.84M | 1.28M | 1.38M | 670.00K | 836.00K | 1.11M |
Cash Flow | ||||||
| Free Cash Flow | 1.25M | -29.00K | 1.67M | -98.00K | -501.00K | 450.00K |
| Operating Cash Flow | 1.28M | 21.00K | 1.71M | -33.00K | -446.00K | 515.00K |
| Investing Cash Flow | -30.00K | -73.00K | -43.00K | -116.00K | -69.00K | -88.00K |
| Financing Cash Flow | -1.13M | -477.00K | -954.00K | -260.00K | 607.00K | -492.00K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | £13.50M | 3.24 | 24.41% | 6.40% | -6.12% | 4.30% | |
71 Outperform | £33.41M | 12.62 | 7.66% | 3.35% | 2.40% | 1101.69% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
58 Neutral | £4.43M | 1.36 | 26.59% | ― | 17.91% | 73.21% | |
54 Neutral | £51.00M | 11.41 | 11.58% | ― | 1.44% | ― | |
46 Neutral | £52.09M | -3.34 | -24.67% | 12.88% | -14.31% | -361.93% | |
40 Underperform | £11.15M | -2.13 | -33.84% | ― | -1.70% | -29.90% |